Steris | STE - Собственный капитал и резервы





Собственный капитал и резервы Изменить Дата
3M USD 4.13B 1.18B 2026-09
Accuray USD 53.42M 8.45M 2025-12
Baxter International USD 6.5B 296M 2026-09
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 25.63B 700M 2026-09
CONMED USD 1.06B 18.53M 2026-09
Cooper Companies USD 8.33B 89.1M 2026-06
Dexcom USD 2.54B 86M 2026-09
Ecolab USD 10.42B 368.4M 2026-09
Edwards Lifesciences USD 10.86B 243.1M 2026-09
Fortive USD 5.95B 122.2M 2026-09
Getinge SEK 30.94B 2.06B 2026-06
Globus Medical USD 4.8B 27.65M 2026-09
Haemonetics USD 898.5M 61.4M 2026-09
Idexx Laboratories USD 1.87B 256.6M 2026-09
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.58B 156.9M 2026-09
Integra LifeSciences USD 1.07B 23.24M 2026-09
Intuitive Surgical USD 15.99B 2.18B 2026-09
J&J USD 81.53B 3.44B 2026-09
Olympus JPY 755.41B 7.51B 2026-09
Orthofix International USD 429.57M 387K 2026-09
Owens Minor USD -568.23M 17.29M 2026-09
ResMed USD 5.95B 637.7M 2026-09
Steris USD 7.21B 23.1M 2026-06
Stryker USD 23.99B 1.01B 2026-06
Tandem Diabetes Care USD 135.09M 4.7M 2026-09
Teleflex USD 3.49B 589.18M 2026-09
Thermo Fisher Scientific USD 54.76B 2.08B 2026-09
Zimmer Biomet Holdings USD 12.72B 83.1M 2026-09